We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Concerns Over ‘FDAAA Effect’ Absent With PDUFA V, FDA Says
Concerns Over ‘FDAAA Effect’ Absent With PDUFA V, FDA Says
June 22, 2012
BOSTON — The FDA should be able to handle the additional requirements of the new iteration of the Prescription Drug User Fee Act (PDUFA V) with little worry of a repeat of the infamously slowed drug reviews from five years ago, agency officials say.